1 Product identity

Ingredient risk

1 ingredient to use with caution

Nema Base

Name: Nema Base
Brand: Nestmann Pharma

BrandNestmann Pharma→Mineral Tablet or Pill 12 ingredients 1 caution DSLD #25336

Net contents: 120 Tablet(s)

Target: Adults and Children 4 years and above

DSLD entry: 2013-09-25

2 Ingredients (12)

IngredientGroupSafety

CalciumCalciumConditionally Safe

MagnesiumMagnesiumUse with Caution

SodiumSodiumConditionally Safe

Sodium BicarbonateSodium Bicarbonate—

Calcium CarbonateCalciumConditionally Safe

Magnesium CarbonateMagnesiumUse with Caution

Dibasic Calcium PhosphateCalciumConditionally Safe

Potassium BicarbonatePotassium Bicarbonate—

MicrocrystallineCellulose—

magnesium stearateMagnesium stearateUse with Caution

natural magnesium silicateMagnesium SilicateUse with Caution

Modified Starchmodified Starch—

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

⚠️ Use with caution — restricted in some markets

Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].

3 Safety cross-reference

Calcium — Conditionally Safe

⚠ Cardiovascular risk debated >1,000 mg/day

⚠ Kidney stones

Magnesium — Use with Caution

⚠ Diarrhea (especially oxide)

⚠ Accumulates in renal impairment

Sodium — Conditionally Safe

⚠ Hypertension

⚠ Fluid retention

Potassium — Limited Evidence

⚠ Hyperkalemia risk

⚠ Dangerous with ACE inhibitors

4 Label claims

• All Other

5 Data source

DSLD ID25336

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2013-09-25

6 More from Nestmann Pharma

View Nestmann Pharma Safety Scorecard → 3 products

Horsetail Tea Nepro Rella

7 Cite this page

Vancouver

Pkhakadze G. Nema Base — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 19]. Available from: https://supplement.ge/products/nema-base-25336/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG